D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.47% |
| 2 | Consumer Discretionary | 13.31% |
| 3 | Healthcare | 13.17% |
| 4 | Financials | 7.14% |
| 5 | Industrials | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Enerpac Tool Group
EPAC
$1.78B
| $1.21M | ﹤0.01% |
49,508
-114,020
| -70% | -$2.67M |
|
2452
Unifirst Corp
UNF
$5.38B
| $1.21M | ﹤0.01% |
+7,858
| New | +$1.1M |
|
2453
Webster Financial
WBS
$12.5B
| $1.21M | ﹤0.01% |
23,807
-32,400
| -58% | -$1.76M |
|
2454
Brown & Brown
BRO
$23.6B
| $1.2M | ﹤0.01% |
40,780
-7,523
| -16% | -$215K |
|
|
TIF
2455
CALL
DELISTED
Tiffany & Co.
TIF
| $1.2M | ﹤0.01% |
11,400
-9,100
| -44% | -$835K |
|
|
PRA
2456
DELISTED
ProAssurance
PRA
| $1.2M | ﹤0.01% |
34,717
-10,861
| -24% | -$440K |
|
2457
KeyCorp
KEY
$24.1B
| $1.2M | ﹤0.01% |
75,906
-9,416
| -11% | -$157K |
|
2458
PUT
Diageo
DEO
$47.3B
| $1.19M | ﹤0.01% |
7,300
-31,200
| -81% | -$4.76M |
|
2459
Guidewire Software
GWRE
$12.4B
| $1.19M | ﹤0.01% |
12,294
-13,805
| -53% | -$1.23M |
|
2460
CALL
American Electric Power
AEP
$72.7B
| $1.18M | ﹤0.01% |
+14,100
| New | +$1.12M |
|
2461
Ventas
VTR
$48.7B
| $1.18M | ﹤0.01% |
18,513
-793,908
| -98% | -$49.6M |
|
2462
Hercules Capital
HTGC
$2.95B
| $1.18M | ﹤0.01% |
93,190
-114,012
| -55% | -$1.45M |
|
2463
PUT
Agnico Eagle Mines
AEM
$73B
| $1.18M | ﹤0.01% |
27,000
-118,400
| -81% | -$5.01M |
|
2464
Realty Income
O
$61.1B
| $1.17M | ﹤0.01% |
16,449
-3,206
| -16% | -$212K |
|
|
LM
2465
PUT
DELISTED
Legg Mason, Inc.
LM
| $1.17M | ﹤0.01% |
42,800
-2,200
| -5% | -$63.1K |
|
2466
PUT
Herc Holdings
HRI
$5.34B
| $1.17M | ﹤0.01% |
30,000
-45,000
| -60% | -$1.7M |
|
|
ESPR
2467
CALL
DELISTED
Esperion Therapeutics
ESPR
| $1.17M | ﹤0.01% |
29,100
+100
| +0.3% | +$4.49K |
|
2468
PUT
HP
HPQ
$24.3B
| $1.17M | ﹤0.01% |
+60,000
| New | +$1.27M |
|
2469
CALL
W.P. Carey
WPC
$17B
| $1.16M | ﹤0.01% |
+15,111
| New | +$1.09M |
|
2470
Wolfspeed
WOLF
$1.24B
| $1.16M | ﹤0.01% |
20,196
-16,763
| -45% | -$860K |
|
2471
B2Gold
BTG
$5.16B
| $1.15M | ﹤0.01% |
411,138
+71,694
| +21% | +$214K |
|
2472
PUT
Under Armour
UAA
$3.02B
| $1.15M | ﹤0.01% |
54,500
-252,600
| -82% | -$5.29M |
|
2473
CALL
Cooper-Standard Automotive
CPS
$508M
| $1.15M | ﹤0.01% |
24,500
+9,500
| +63% | +$611K |
|
2474
CALL
National Health Investors
NHI
$3.84B
| $1.15M | ﹤0.01% |
14,600
+10,900
| +295% | +$866K |
|
|
MDC
2475
DELISTED
M.D.C. Holdings, Inc.
MDC
| $1.15M | ﹤0.01% |
42,639
-88,475
| -67% | -$2.34M |
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.